Xtrackers MSCI Korea UCITS ETF(02848.HK) Fell 3.62% to 1675.000
Newtimespace News, as of 11:26 on May 20, Xtrackers MSCI Korea UCITS ETF(02848.HK) was quoted at HKD 1675.000, down 3.62%. The ETF opened at HKD 1740.000, with a high of HKD 1740.000 and a low of HKD 1675.000. The latest Net Asset Value (NAV) per unit is HKD 1793.305, with a premium rate of --. The asset size is approximately HKD 3.178 billion.
Xtrackers MSCI Korea UCITS ETF(02848.HK) tracks the MSCI Korea 20/35 Custom Index, which is compiled and published by MSCI Inc. This index is a "capped index" designed by MSCI to comply with regulatory requirements. While maintaining the representativeness and investability of the Korean large- and mid-cap equity market, it reduces single-stock risk through hard weight caps (no single constituent exceeding 20%, and the combined weight of the top five constituents not exceeding 35%). The index's constituent stocks cover core Korean leading companies such as Samsung Electronics, SK Hynix, and NAVER, providing a relatively balanced reflection of the overall performance of the Korean stock market.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million